| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 07/27/1999 | US5929063 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 07/27/1999 | US5929054 Use of NK-1 receptor antagonists for treating sexual dysfunctions |
| 07/27/1999 | US5929028 Liquid gonadotropin containing formulations |
| 07/27/1999 | US5928874 Nek1-related protein kinase |
| 07/27/1999 | CA2170700C Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
| 07/27/1999 | CA2155837C Benzopyrans as potassium channel openers |
| 07/22/1999 | WO1999036540A1 Human chemokine and its use for detection and treatment of breast disease |
| 07/22/1999 | WO1999036080A1 St. john's wort and methyl donor composition and uses thereof |
| 07/22/1999 | WO1999036063A2 Vanadium (iv) metallocene complexes having spermicidal activity |
| 07/22/1999 | CA2318159A1 Vanadium (iv) metallocene complexes having spermicidal activity |
| 07/22/1999 | CA2317810A1 Human chemokine and its use for detection and treatment of breast disease |
| 07/22/1999 | CA2317671A1 St. john's wort and methyl donor composition and uses thereof |
| 07/21/1999 | EP0929554A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 07/21/1999 | EP0929315A2 Cross-protective equine herpesvirus preparations and method of making and using the same |
| 07/21/1999 | EP0929295A1 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive |
| 07/21/1999 | CN1223690A Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 07/21/1999 | CN1223641A Aryl pyrimidine derivatives |
| 07/21/1999 | CN1223581A Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics |
| 07/21/1999 | CN1223140A Health care food and production method thereof |
| 07/21/1999 | CN1223119A Traditional Chinese medicinal preparation for curing gynecopathy |
| 07/21/1999 | CN1044235C Sulfonamide endothelin antagonists |
| 07/21/1999 | CN1044234C Substituted phenylimidazolidines, their preparation process, their use as medicaments and the pharmaceutical compositions containing them |
| 07/20/1999 | US5925730 Decapeptide gonadotrophin releasing hormone antagonists; for antifertility agents especially for males; precocious puberty; dysmenorrhea; antitumor/anticarcinogenic agents; endometriosis |
| 07/20/1999 | US5925619 Formulation for peptide release |
| 07/20/1999 | US5925557 This invention relates generally to the field of protein kinases, oncogenes and oncoproteins and, specifically, to a protein kinase which phosphorylates and potentiates the activity of c-fos. |
| 07/20/1999 | US5925351 Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 07/20/1999 | CA2146367C Calcium channel blocking polypeptides from heteropoda venatoria |
| 07/20/1999 | CA2060223C Injectable medical lubricating fluid composition and method of use |
| 07/20/1999 | CA1340667C Peptides having bradykinin antagonist action |
| 07/15/1999 | WO1999035252A2 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035124A1 Matrix metalloprotease inhibitors |
| 07/15/1999 | WO1999034825A1 Fertility impairing vaccine and method of use |
| 07/15/1999 | WO1999024027A3 Anti-estrogen plus progestin containing oral contraceptives |
| 07/15/1999 | CA2316864A1 Secreted proteins and polynucleotides encoding them |
| 07/14/1999 | EP0665833B1 Dopamine receptor subtype ligands |
| 07/13/1999 | US5922747 Comprising testosterone reductase used for treatment of acne, alopacia, skin and glandular disorders, prostatic hypertropy, |
| 07/13/1999 | US5922700 Kit for drug delivery of steroids |
| 07/13/1999 | US5922590 Hic-1 is a marker which can be used diagnostically, prognostically and therapeutically over the course of such disorders. |
| 07/13/1999 | US5922349 Dispensing non-discrete doses of estrogen and progestogen concurrently onto delivery surface and transferring dispensed doses to site of administration, repeating the procedure on predetermined schedule, periodically varying dosage |
| 07/13/1999 | CA1340653C Method for improving reproductive functions in mammals |
| 07/13/1999 | CA1340649C Purified follicle stimulating hormone |
| 07/08/1999 | WO1999033974A1 Serine proteinase inhibitors |
| 07/08/1999 | WO1999033834A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/08/1999 | WO1999033831A1 Nitrogen-containing heterocyclic compounds, their production and use |
| 07/08/1999 | CA2315144A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/08/1999 | CA2300479A1 Nitrogen-containing heterocyclic compounds, their production and use |
| 07/07/1999 | EP0927248A1 Secreted proteins and polynucleotides encoding them |
| 07/07/1999 | EP0927183A1 Spirocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927177A1 Novel benzothiophene derivatives, their preparation and use as urokinase inhibitors |
| 07/07/1999 | EP0927170A1 Piperazino derivatives as neurokinin antagonists |
| 07/07/1999 | EP0927040A1 Process to obtain oestrogens from mare's urine |
| 07/07/1999 | EP0500807B1 Tissue moisturizing composition and method |
| 07/06/1999 | US5919455 Non-antigenic branched polymer conjugates |
| 07/06/1999 | CA2004764C Ancrod proteins, their preparation and use |
| 07/01/1999 | WO1999032614A1 Secreted proteins and polynucleotides encoding them |
| 07/01/1999 | WO1999032506A1 17β-ARYL (ARYLMETHYL) OXY(THIO)ALKYL -ANDROSTANE DERIVATIVES |
| 07/01/1999 | WO1999032460A1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 07/01/1999 | WO1999032144A1 Method for preventing/remedying mastitis |
| 07/01/1999 | CA2315245A1 Secreted proteins and polynucleotides encoding them |
| 06/30/1999 | EP0925791A1 Preventive and/or therapeutic agent for kidney diseases |
| 06/30/1999 | EP0925298A1 Substituted 6,6-hetero-bicyclic derivatives |
| 06/30/1999 | EP0925287A1 Heterocyclic metalloprotease inhibitors |
| 06/30/1999 | EP0925071A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
| 06/30/1999 | EP0925057A1 Bowman-birk inhibitor for male sexual dysfunction |
| 06/30/1999 | CN1221347A Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 06/30/1999 | CN1221343A Phosphatidic acid-comprising compositions |
| 06/29/1999 | US5916768 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 06/29/1999 | US5916569 Human erectile dysfunction and methods of treatment |
| 06/24/1999 | WO1999031232A1 Human brain derived kcnq2 potassium channel |
| 06/24/1999 | WO1999031128A2 Human tumor necrosis factor-r2-like proteins |
| 06/24/1999 | WO1999031117A1 110 human secreted proteins |
| 06/24/1999 | WO1999031077A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 06/24/1999 | WO1999030749A1 Use of odorants to alter vaginal blood flow, and article of manufacture therefor |
| 06/24/1999 | WO1999030708A2 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 06/24/1999 | WO1999030701A1 Method of the prophylactic treatment of mastitis |
| 06/24/1999 | WO1999030697A2 Combination effective for the treatment of impotence |
| 06/24/1999 | WO1999030670A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 06/24/1999 | WO1999005155A3 Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof |
| 06/24/1999 | DE19756388A1 New 2-aryl-4-amino-6,7-di:methoxy-quinazoline derivatives useful as guanylate cyclase activators for treating cardiovascular diseases, etc. |
| 06/24/1999 | DE19756036A1 New indole amide derivatives |
| 06/24/1999 | CA2506802A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 06/24/1999 | CA2315295A1 110 human secreted proteins |
| 06/24/1999 | CA2314993A1 Combination effective for the treatment of impotence |
| 06/24/1999 | CA2314884A1 Human tumor necrosis factor-r2-like proteins |
| 06/24/1999 | CA2312347A1 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 06/23/1999 | EP0924205A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 06/23/1999 | EP0923740A2 Methods and compositions for the detection of cervical cancer |
| 06/23/1999 | EP0923602A1 Immunocontraceptive compositions containing sperm antigens, and methods of use |
| 06/23/1999 | EP0923582A1 Substituted 6,5-hetero-bicyclic derivatives |
| 06/23/1999 | EP0923563A1 1,4-heterocyclic metallprotease inhibitors |
| 06/23/1999 | EP0923530A1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 06/23/1999 | EP0923529A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 06/23/1999 | CN1220155A Traditional Chinese medicine essence-replenishing preparation |
| 06/22/1999 | US5914338 Heterocyclic compounds and their preparation and use |
| 06/22/1999 | US5914330 Administering an imidazole-containing pyrimidine derivative effective to protect against renal failure without reducing blood pressure |
| 06/17/1999 | WO1999029878A2 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 06/17/1999 | WO1999029856A1 Restin and methods of use thereof |
| 06/17/1999 | WO1999029855A1 Mutants of endostatin, 'em 1' having anti-angiogenic activity and methods of use thereof |
| 06/17/1999 | WO1999029313A1 Method of increasing the production and improving the quality of semen |
| 06/17/1999 | CA2313705A1 Restin and methods of use thereof |